Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Jacobsen22,10.1038/s41598-022-22552-y,Pseudovirus (VSV),41598_2022_22552_MOESM2_ESM.xlsx,None,Ad26.COV2.S,1,1m,Human,Wild Type (B.1),=,20.3,1.0,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,<,1.0,1.0,>,20.3
Jacobsen22,10.1038/s41598-022-22552-y,Pseudovirus (VSV),41598_2022_22552_MOESM2_ESM.xlsx,None,Ad26.COV2.S,1,1m,Human,Wild Type (B.1),=,18.9,1.0,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,<,1.0,1.0,>,18.9
Jacobsen22,10.1038/s41598-022-22552-y,Pseudovirus (VSV),41598_2022_22552_MOESM2_ESM.xlsx,None,Ad26.COV2.S,1,1m,Human,Wild Type (B.1),=,14.8,1.0,Omicron/BA.3,67,A67V + Δ69-70 + T95I + G142D + Δ143-145 + N211I + Δ212 + G339D + S371F + S373P + S375F + D405N + K417N + N440K + G446S + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + N764K + D796Y + Q954H + N969K,1,<,1.0,1.0,>,14.8